An open-label acceptability study of Norditropin SimpleXx - A new liquid growth hormone formulation

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue 6, 2001, Pages 735-740

  Stanhope, R ^a   Buchanan, C ^a   Butler, G ^a   Costigan, C ^a   Dunger, D ^a   Greene, S ^a   Hoey, H ^a   Hughes, I ^a   Kelnar, C ^a   Kirk, J ^a   Komulainen, J ^a   Lowry, M ^a   Warner, J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Growth hormone deficiency; Growth retardation; Human growth hormone; Liquid formulation; Norditropin simpleXx; Pen device

Indexed keywords

HUMAN GROWTH HORMONE; NORDITROPIN SIMPLEXX; UNCLASSIFIED DRUG;

ADOLESCENT; AGE; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TOLERABILITY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE; NURSE; PAIN; PARENT; PATIENT ATTITUDE; PATIENT SATISFACTION; QUESTIONNAIRE; SELF INJECTION; SIDE EFFECT; TIME; TURNER SYNDROME;

EID: 0034956581     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2001.14.6.735     Document Type: Article

References (9)

1. Psychosocial impact of long-term growth hormone therapy
2. Automatic needle insertion diminishes pain during growth hormone injection
3. What makes insulin injections painful?
4. Acceptability of Nordiject®. A new drug delivery system for growth hormone
5. Compliance with growth hormone treatment - Are they getting it?
6. Increased growth rate following transfer to daily sc administration from three weekly in injections of hGH in growth hormone deficient children
7. Pharmacological aspects of growth hormone replacement therapy: Route, frequency and timing of administration
8. Evening versus morning injections of growth hormone (GH) in GH-deficient patients: Effects on 24-hour patterns of circulating hormones and metabolites
9. Pharmacokinetic aspects of growth hormone therapy